This cohort study evaluates clinical effectiveness and reasons for discontinuation of dupilumab treatment in children, adults, and older adults with atopic dermatitis with up to 5 years of treatment in daily practice.

Smoking Cessation and Risk of Hidradenitis Suppurativa Development

Seong Rae Kim, MD; Young-Geun Choi, PhD; Seong Jin Jo, MD, PhD

Abstract Full Text

JAMA Dermatol. 2024;160(10):1056-1065. doi:10.1001/jamadermatol.2024.2613

This cohort study examines the association between changes in smoking status and the development of hidradenitis suppurativa.

Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial

April W. Armstrong, MD, MPH; Melinda Gooderham, MD; Charles Lynde, MD; et al.

Abstract Full Text

open access

JAMA Dermatol. 2024;160(10):1066-1074. doi:10.1001/jamadermatol.2024.2701

This randomized clinical trial examines the efficacy, safety, and tolerability of zasocitinib in patients with moderate to severe plaque psoriasis.

Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata: The BRAVE-AA1 Randomized Clinical Trial

Brett King, MD, PhD; Justin Ko, MD; Ohsang Kwon, MD; et al.

Abstract Full Text

open access

JAMA Dermatol. 2024;160(10):1075-1081. doi:10.1001/jamadermatol.2024.2734

This randomized clinical trial examines short-term and long-term relapse rates following treatment withdrawal in patients with severe alopecia areata.

Prenatal Fish Oil Supplementation, Maternal COX1 Genotype, and Childhood Atopic Dermatitis: A Secondary Analysis of a Randomized Clinical Trial

Liang Chen, MSc; Nicklas Brustad, MD, PhD; Yang Luo, MSc; et al.

Abstract Full Text

JAMA Dermatol. 2024;160(10):1082-1090. doi:10.1001/jamadermatol.2024.2849

The secondary analysis of a randomized clinical trial examines whether prenatal ω-3 long-chain polyunsaturated fatty acid (ie, fish oil) supplementation is associated with risk of atopic dermatitis in offspring to 10 years of age overall and by maternal cyclooxygenase-1 genotype.

Cutaneous Neurofibromas and Quality of Life in Adults With Neurofibromatosis Type 1

Michelle Jade Lin, BS; Hanqi Yao, BA; Katya Vera, BA; et al.

Abstract Full Text

has audio

JAMA Dermatol. 2024;160(10):1091-1098. doi:10.1001/jamadermatol.2024.2912

This cross-sectional study examines the association of cutaneous neurofibroma features with quality of life in patients with neurofibromatosis type 1.

Audio: Cutaneous Neurofibromas and Quality of Life in Adults With Neurofibromatosis Type 1

Consensus on a Patient-Centered Definition of Atopic Dermatitis Flare

Aaron M. Drucker, MD, ScM; Isabelle J. C. Thibau, MPH; Bryan Mantell, BS; et al.

Abstract Full Text

open access

JAMA Dermatol. 2024;160(10):1099-1106. doi:10.1001/jamadermatol.2024.3054

This consensus survey study uses a modified eDelphi approach to identify a patient-centered, consensus-based working definition of atopic dermatitis.

Brief Report

Skin Cancer and Other Dermatologic Conditions Among US Veterans

Shawheen J. Rezaei, MPhil; Jiyeong Kim, PhD, MPH; Sonia Onyeka, MBBS; et al.

Abstract Full Text

JAMA Dermatol. 2024;160(10):1107-1111. doi:10.1001/jamadermatol.2024.3043

This cross-sectional study assesses the prevalence and likelihood of various dermatologic conditions and skin cancer risk factors among US veterans compared with nonveterans.

Cord Blood Serum Levels of IL-31 and CCL17, Cutaneous Markers, and Development of Atopic Dermatitis

Angelo Massimiliano D’Erme, MD, PhD; Cristian Fidanzi, MD; Matteo Bevilacqua, MD; et al.

Abstract Full Text

JAMA Dermatol. 2024;160(10):1112-1115. doi:10.1001/jamadermatol.2024.3178

This observational study evaluates the predictive value of serological biomarkers with transepidermal water loss and hydration rate and the development of atopic dermatitis in infants.

Images in Dermatology

Linear Depigmentation After Local Corticosteroid Injection

Nikhil Mehta, MD; Roopanjit Singh Aulakh, MBBS

Abstract Full Text

has active quiz

JAMA Dermatol. 2024;160(10):1116-1117. doi:10.1001/jamadermatol.2024.2071

This case report describes a linear branching depigmentation with skin atrophy extending from the wrist to the mid-arm of a school-aged boy.

CLAPO Syndrome

Andrew X. Tran, MD; Lisa Gelles, MD

Abstract Full Text

has active quiz

JAMA Dermatol. 2024;160(10):1118-1119. doi:10.1001/jamadermatol.2024.2526

A 1-day-old, healthy, full-term boy born by cesarean delivery for placental abruption to a 31-year-old primigravid mother was noted at birth to have an erythematous patch on his lower lip.

JAMA Dermatology Clinicopathological Challenge

Umbilicated Nodular Ulcerative Lesions in a Patient With Previous Kidney Transplant

Bhukampa Acharya, MBBS; Kumari Sweta Leena Patra, MBBS; Tarun Narang, MD, MNAMS

Abstract Full Text

has active quiz

JAMA Dermatol. 2024;160(10):1120-1121. doi:10.1001/jamadermatol.2024.2102

A man in his 70s presented with 2 enlarging, painless nodular lesions on the forehead and right cheek. Histopathological examination showed extensive dermal collection of lymphocytes, histiocytes, and macrophages. What is your diagnosis?

Pustular Erythroderma in an Infant

Mandana Fadaei Kermani, BS; Jerome Coulombe, MD

Abstract Full Text

has active quiz

JAMA Dermatol. 2024;160(10):1122-1123. doi:10.1001/jamadermatol.2024.2436

An infant boy presented with generalized rash, fever, and severe skin pain. What is your diagnosis?

Research Letter

Epidermolysis Bullosa Pruriginosa Treated With Upadacitinib

Zeqiao Zhang, MD; Zhimiao Lin, MD

Abstract Full Text

JAMA Dermatol. 2024;160(10):1124-1125. doi:10.1001/jamadermatol.2024.2787

This case series measured the results of using upadacitinib for moderate or severe cases of epidermolysis bullosa pruriginosa.

Genetic Aspects of Necrobiotic Xanthogranuloma

Peng-Yu Chen, MM; Zhuang-Li Tang, MD, PhD; Yuan-Yu Hong, MM; et al.

Abstract Full Text

JAMA Dermatol. 2024;160(10):1125-1128. doi:10.1001/jamadermatol.2024.2921

This genetic association study examines the genetic aspects of necrobiotic xanthogranuloma in 3 patients in China.

Incidence and Prevalence of Morphea

Heejo Keum, MD; Henry W. Chen, MD; Robert W. Haley, MD; et al.

Abstract Full Text

JAMA Dermatol. 2024;160(10):1128-1130. doi:10.1001/jamadermatol.2024.2993

This cohort study uses population-based data to estimate the incidence and prevalence of morphea in the US among patients of all ages.

Observation

Cutaneous Collagenous Vasculopathy Associated With Antibody-Drug Conjugate Treatment

Andrea Michelerio, MD, PhD; Francesco Cabutti, MD; Carlo Tomasini, MD

Abstract Full Text

JAMA Dermatol. 2024;160(10):1130-1132. doi:10.1001/jamadermatol.2024.2324

This case report describes cutaneous collagenous vasculopathy associated with loncastuximab tesirine, an antibody-drug conjugate treatment.

Revertant Mosaic Skin Punch Grafting in Recessive Dystrophic Epidermolysis Bullosa

Ahreum Song, MD, MS; Gue-Ho Hwang, PhD; Song-Ee Kim, MS; et al.

Abstract Full Text

JAMA Dermatol. 2024;160(10):1132-1135. doi:10.1001/jamadermatol.2024.2543

This case report describes a patient with severe generalized recessive dystrophic epidermolysis bullosa who presented with an unhealed ulcer that had persisted for the past 3 years.

Comment & Response

Fear of Cancer Recurrence Among Survivors of Localized Cutaneous Melanoma—What’s in a Name?

Elliot H. Akama-Garren, PhD; Rebecca I. Hartman, MD, MPH

Abstract Full Text

JAMA Dermatol. 2024;160(10):1135. doi:10.1001/jamadermatol.2024.2817

Fear of Cancer Recurrence Among Survivors of Localized Cutaneous Melanoma—What’s in a Name?—Reply

Ayisha N. Mahama, MD, MPH; Courtney N. Haller, MD; Adewole S. Adamson, MD, MPP

Abstract Full Text

JAMA Dermatol. 2024;160(10):1135-1136. doi:10.1001/jamadermatol.2024.2816

Orofacial Manifestations of Kindler Epidermolysis Bullosa

Kaiyang Li, BSc; Chaocheng Liu, MD; Wei Guang Bi, DMD

Abstract Full Text

JAMA Dermatol. 2024;160(10):1136-1137. doi:10.1001/jamadermatol.2024.2837

Orofacial Manifestations of Kindler Epidermolysis Bullosa—Reply

Susanne Krämer, DDS, MSc; Agnes Bloch-Zupan, PhD; Cristina Has, MD

Abstract Full Text

JAMA Dermatol. 2024;160(10):1137. doi:10.1001/jamadermatol.2024.2830

October 2024, Vol 160, No. 10, Pages 1036-1137

Equipping Dermatologists to Address Structural and Social Drivers of Inequities—Structural Competency

Smoking Cessation and Hidradenitis Suppurativa: Advances and Treatment Gaps

Skin Cancer Care in US Veterans—Serving Those Who Served

Long-Term Effectiveness and Reasons for Discontinuation of Dupilumab in Patients With Atopic Dermatitis

Smoking Cessation and Risk of Hidradenitis Suppurativa Development

Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial

Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata: The BRAVE-AA1 Randomized Clinical Trial

Prenatal Fish Oil Supplementation, Maternal COX1 Genotype, and Childhood Atopic Dermatitis: A Secondary Analysis of a Randomized Clinical Trial

Cutaneous Neurofibromas and Quality of Life in Adults With Neurofibromatosis Type 1

Consensus on a Patient-Centered Definition of Atopic Dermatitis Flare

Skin Cancer and Other Dermatologic Conditions Among US Veterans

Cord Blood Serum Levels of IL-31 and CCL17, Cutaneous Markers, and Development of Atopic Dermatitis

Linear Depigmentation After Local Corticosteroid Injection

CLAPO Syndrome

Umbilicated Nodular Ulcerative Lesions in a Patient With Previous Kidney Transplant

Pustular Erythroderma in an Infant

Epidermolysis Bullosa Pruriginosa Treated With Upadacitinib

Genetic Aspects of Necrobiotic Xanthogranuloma

Incidence and Prevalence of Morphea

Cutaneous Collagenous Vasculopathy Associated With Antibody-Drug Conjugate Treatment

Revertant Mosaic Skin Punch Grafting in Recessive Dystrophic Epidermolysis Bullosa

Fear of Cancer Recurrence Among Survivors of Localized Cutaneous Melanoma—What’s in a Name?

Fear of Cancer Recurrence Among Survivors of Localized Cutaneous Melanoma—What’s in a Name?—Reply

Orofacial Manifestations of Kindler Epidermolysis Bullosa

Orofacial Manifestations of Kindler Epidermolysis Bullosa—Reply

JAMA Dermatology

New Online

Featured Articles

USPSTF Recommendation Statements

Blogs